Scout | Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)

This grant aims to study microglial protein profiles in specific brain regions and cell types related to HIV and substance use disorders (SUD). The research will use these profiles to understand how HIV-infected microglia contribute to brain diseases in individuals with both HIV and SUD.

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Dates

Opportunity Released: July 19, 2023

Open for Submission: July 19, 2023

Submission Deadline: August 14, 2025

Application Window Closes: August 14, 2025

Keywords

HIV

SUD

microglia

protein profiles

neuropathology

brain regions

cell-type specific

molecular interaction networks

comorbid conditions

neurobiology

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers